Get the Stockscreener App
174.21
1.32%
-2.33
After Hours:
174.04
-0.17
-0.10%
Overview
News
Price History
Option Chain
Financials
Why BDX Down?
Discussions
Forecast
Stock Split
Dividend History
Becton Dickinson Co stock is traded at $174.21, with a volume of 1.76M.
It is down -1.32% in the last 24 hours and down -15.64% over the past month.
Becton Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments, and reagents, as well as flow cytometry and cell-imaging systems. On a 2025 sales basis, following the spinoff, BD Medical Essentials represented 34% of revenue, the Interventional segment 28%, Connected Care 25%, and Biopharma 13%. International revenue accounts for 43% of the company's business.
See More
Previous Close:
$176.54
Open:
$173.23
24h Volume:
1.76M
Relative Volume:
0.80
Market Cap:
$49.56B
Revenue:
$21.92B
Net Income/Loss:
$1.76B
P/E Ratio:
28.45
EPS:
6.1223
Net Cash Flow:
$2.63B
1W Performance:
-4.54%
1M Performance:
-15.64%
6M Performance:
-8.12%
1Y Performance:
-23.74%
1-Day Range:
$171.57
$174.99
1-Week Range:
$171.57
$183.73
52-Week Range:
$162.29
$235.34
Becton Dickinson Co Stock (BDX) Company Profile
Name
Becton Dickinson Co
Sector
Industry
Phone
(201) 847-6800
Address
ONE BECTON DR, FRANKLIN LAKES
Compare BDX vs ISRG, ALC, RMD, MDLN
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDX
Becton Dickinson Co
|
174.21 | 50.22B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ISRG
Intuitive Surgical Inc
|
497.42 | 176.23B | 10.06B | 2.88B | 2.49B | 7.876 |
|
ALC
Alcon Inc
|
83.08 | 41.28B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
258.28 | 37.50B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
44.39 | 37.20B | 27.43B | 1.27B | 1.01B | 1.5829 |
Becton Dickinson Co Stock (BDX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-10-26 | Resumed | Barclays | Overweight |
| Feb-03-26 | Resumed | Citigroup | Buy |
| Sep-25-25 | Initiated | RBC Capital Mkts | Sector Perform |
| May-22-25 | Downgrade | Citigroup | Buy → Neutral |
| May-02-25 | Downgrade | Goldman | Buy → Neutral |
| May-02-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| May-02-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| May-01-25 | Downgrade | BofA Securities | Buy → Neutral |
| May-01-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| May-01-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Oct-01-24 | Upgrade | Citigroup | Neutral → Buy |
| May-30-24 | Initiated | Goldman | Buy |
| Jul-24-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| May-30-23 | Resumed | Morgan Stanley | Overweight |
| May-05-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Apr-12-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Jan-03-23 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-12-22 | Upgrade | Citigroup | Sell → Neutral |
| Jul-11-22 | Downgrade | Citigroup | Neutral → Sell |
| Jun-24-22 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-18-22 | Resumed | Raymond James | Mkt Perform |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Dec-08-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-06-21 | Downgrade | JP Morgan | Overweight → Neutral |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Dec-15-20 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jul-09-20 | Upgrade | Barclays | Equal Weight → Overweight |
| Jun-01-20 | Resumed | Goldman | Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-07-20 | Downgrade | Cowen | Outperform → Market Perform |
| Feb-07-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Feb-07-20 | Downgrade | Raymond James | Strong Buy → Outperform |
| Feb-06-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-08-20 | Downgrade | Barclays | Overweight → Equal Weight |
| May-13-19 | Upgrade | Barclays | Equal Weight → Overweight |
| Dec-07-18 | Initiated | Deutsche Bank | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Jun-21-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Apr-10-18 | Upgrade | Citigroup | Neutral → Buy |
| Jan-19-18 | Resumed | BofA/Merrill | Buy |
| Jan-05-18 | Upgrade | Citigroup | Sell → Neutral |
| Jan-05-18 | Initiated | KeyBanc Capital Mkts | Overweight |
| Jan-03-18 | Initiated | Evercore ISI | Outperform |
| Dec-29-17 | Reiterated | Deutsche Bank | Buy |
View All
Becton Dickinson Co Stock (BDX) Latest News
Becton, Dickinson and Company $BDX Stake Boosted by First Eagle Investment Management LLC - MarketBeat
Elo Mutual Pension Insurance Co Increases Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company (BDX) Stock Analysis: Exploring a Potential 11.71% Upside in the Healthcare Sector - DirectorsTalk Interviews
Becton Dickinson (BDX) Secures FDA Clearance for Innovative Irri - GuruFocus
Becton, Dickinson and Company $BDX Position Trimmed by Laurel Wealth Advisors LLC - MarketBeat
BD Pioneers New Standard in Surgical Safety with FDA-Cleared Surgiphor 1000mL for Wound Irrigation - Finviz
FDA clears 1L surgical rinse designed to boost safety in the OR - Stock Titan
Is Becton, Dickinson and Company Stock Outperforming the Dow? - inkl
Xponance Inc. Reduces Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
DNB Asset Management AS Reduces Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company Trade Ideas — LSX:857675 - TradingView
Becton, Dickinson and Company (BDX): A Bull Case Theory - Finviz
American Century Companies Inc. Sells 162,854 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company (NYSE:BDX) EVP Sells $13,638.00 in Stock - MarketBeat
Feld, Becton Dickinson’s EVP, sells $13,638 in stock - Investing.com
Mitsubishi UFJ Asset Management Co. Ltd. Increases Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Close Asset Management Ltd Sells 395,644 Shares of Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company (BDX) Insider Trading Activity 2026 $BDX - MarketBeat
Becton Dickinson & Co. stock underperforms Thursday when compared to competitors - MarketWatch
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $195 - 富途牛牛
Becton, Dickinson and Company (BDX) Announces Early Tender Resul - GuruFocus
Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase - investors.bd.com
Becton Dickinson Expands Debt Tender Offers Amid Strong Demand - TipRanks
Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap - Becton Dickinson
Point of Care Diagnostics Market Competitive Landscape - GlobeNewswire
Point of Care Diagnostics Market Competitive Landscape Report 2025 Featuring Top 5 PlayersSysmex, Abbott Laboratories, Becton Dickinson and Co, Danaher, Quidel Diagnostics - Yahoo Finance
Becton Dickinson hires Walgreens Boots Alliance CLO as next legal head - The Global Legal Post
Becton, Dickinson and Company (BDX) Stock Analysis: Assessing Growth Potential with a 5.39% Upside - DirectorsTalk Interviews
BD Expands Testing Capabilities to Help Clinicians Improve Diagnostic Accuracy and Efficiency - Finviz
New BD urine test kit aims to cut repeat samples, reduce contamination - Stock Titan
Becton Dickinson Sharpens Focus Through Strategic Financial Moves - AD HOC NEWS
Tredje AP fonden Grows Stake in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson stock hits 52-week high at 185.0 USD By Investing.com - Investing.com India
Becton, Dickinson and Company (NYSE:BDX) Reaches New 12-Month HighHere's What Happened - MarketBeat
Former Walgreens Legal Chief Joins Medical Device Giant Becton Dickinson - Law.com
Becton Dickinson stock hits 52-week high at 185.0 USD - Investing.com
BDX SEC FilingsBecton Dickinson & Co 10-K, 10-Q, 8-K Forms - Stock Titan
Lanesha Minnix Named General Counsel for BD - citybiz
Walgreens deal veteran Lanesha Minnix to lead BD legal and public affairs - Stock Titan
First National Bank of Omaha Acquires New Holdings in Becton, Dickinson and Company $BDX - MarketBeat
BD CEO says 'lean manufacturing'—Toyota's famous philosophy—is prerequisite for leveraging AI - Fortune
Becton, Dickinson and Company $BDX Shares Sold by HighTower Advisors LLC - MarketBeat
Insider Sell: Bertram Scott Sells Shares of Becton Dickinson & C - GuruFocus
Becton, Dickinson and Company (NYSE:BDX) Director Sells 953 Shares - MarketBeat
Becton Dickinson & Co. stock outperforms competitors on strong trading day - MarketWatch
Reassessing Becton Dickinson (BDX) After Recent Share Price Volatility - Yahoo Finance
First Pacific Advisors' Strategic Moves: Spotlight on Becton Dic - GuruFocus
First Pacific Advisors' Strategic Moves: Spotlight on Becton Dickinson & Co - Yahoo Finance
Fund Update: 1,014,989 BECTON, DICKINSON (BDX) shares added to First Pacific Advisors, LP portfolio - Quiver Quantitative
Hemostasis Products Market Size to Reach USD 3.28 Billion by 2035 with 5.41% CAGR – SNS Insider - GlobeNewswire Inc.
Vanguard Group Inc. Increases Stock Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson Co Stock (BDX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.89%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):